Le dépistage du cancer du poumon

Revue des Maladies Respiratoires Actualités - Tập 14 - Trang 2S37-2S41 - 2022
B. Milleron1, S. Couraud2, E. Grolleau2, V. Gounant2
1Intergroupe Francophone de Cancérologie Thoracique, 75009 Paris, France
2Service de Pneumologie Aigue Spécialisée et cancérologie Thoracique, Hôpital Lyon Sud, Institut de Cancérologie des Hospices Civils de Lyon, 69495 Pierre bénite, France

Tài liệu tham khảo

Goldstraw, 2016, The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer, J Thorac Oncol Off Publ Int Assoc Study Lung Cancer, 11, 39

Locher, 2013, Major changes in lung cancer over the last ten years in France: The KBP-CPHG studies, Lung Cancer Amst Neth, 81, 32, 10.1016/j.lungcan.2013.03.001

Raz, 2007, Natural history of stage I non-small cell lung cancer: implications for early detection, Chest, 132, 193, 10.1378/chest.06-3096

Cao, 2013, Video-assisted thoracic surgery versus open thoracotomy for non-small cell lung cancer: a meta-analysis of propensity score-matched patients, Interact Cardiovasc Thorac Surg, 16, 244, 10.1093/icvts/ivs472

Aberle, 2011, Reduced lung-cancer mortality with low-dose computed tomographic screening, N Engl J Med, 365, 395, 10.1056/NEJMoa1102873

Oken, 2011, Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial, JAMA J Am Med Assoc, 306, 1865, 10.1001/jama.2011.1591

Horeweg, 2013, Participants’ Results Of Three Rounds Of The Randomised Dutch-Belgian Lung Cancer Screening Trial; A Volumetry-Based Computer Tomography Screening Strategy, Am J Respir Crit Care Med, 187, A2344

de Koning, 2020, Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial, N Engl J Med, 6, 503, 10.1056/NEJMoa1911793

2021, Screening for Lung Cancer US Preventive Services Task Force Recommendation Statement, JAMA, 325, 962, 10.1001/jama.2021.1117

Xu, 2006, Nodule management protocol of the NELSON randomised lung cancer screening trial, Lung Cancer, 54, 177, 10.1016/j.lungcan.2006.08.006

Horeweg, 2013, Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial, Eur Respir J, 42, 1659, 10.1183/09031936.00197712

van Klaveren, 2009, Management of lung nodules detected by volume CT scanning, N Engl J Med, 361, 2221, 10.1056/NEJMoa0906085

Pastorino, 2019, Prolonged Lung Cancer Screening Reduced 10-year Mortality in the MILD Trial, Ann Oncol, 30, 1162, 10.1093/annonc/mdz117

Black, 2019, Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial National Lung Screening Trial Writing Team 1, J Thorac Oncol, 14, 1732, 10.1016/j.jtho.2019.05.044

Marcus, 2006, Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis, J Natl Cancer Inst, 98, 748, 10.1093/jnci/djj207

Potter, 2022, Association of computed tomography screening with lung cancer stage shift and survival in the United States: quasi-experimental study, Brit Med J, 376, e069008, 10.1136/bmj-2021-069008

Couraud, 2013, Ann Oncol Off J Eur Soc Med Oncol ESMO, 24, 586, 10.1093/annonc/mds476

Couraud, 2021, Recommandations de l’Intergroupe francophone de cancérologie thoracique, de la Société de pneumologie de langue française, et de la Société d’imagerie thoracique sur le dépistage du cancer bronchopulmonaire par tomodensitométrie à faible dose d’irradiation, Rev Mal Respir, 7138, 225

Patz, 2016, Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial, Lancet Oncol, 17, 590, 10.1016/S1470-2045(15)00621-X

Yousaf-Khan, 2017, Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval, Thorax, 72, 48, 10.1136/thoraxjnl-2016-208655

Kauczor, 2020, ESR/ERS statement paper on lung cancer screening, Eur Respir J, 55

Carreras, 2012, Can a national lung cancer screening program in combination with smoking cessation policies cause an early decrease in tobacco deaths in Italy?, Cancer Prev Res Phila, 5, 874, 10.1158/1940-6207.CAPR-12-0019

Gendarme, 2017, Economic impact of lung cancer screening in France: A modeling study, Rev Mal Respir, 34, 717, 10.1016/j.rmr.2015.10.004

Brenner, 2007, Computed tomography--an increasing source of radiation exposure, N Engl J Med, 357, 2277, 10.1056/NEJMra072149

Kong, 2012, Using radiation risk models in cancer screening simulations: important assumptions and effects on outcome projections, Radiology, 262, 977, 10.1148/radiol.11110352

https://www.has-sante.fr/jcms/c_2001613/fr/pertinence-du-depistage-du-cancer-broncho-pulmonaire-en-france-point-de-situation-sur-les-donnees-disponibles-analyse-critique-des-etudes-controlees-randomisees

https://www.has-sante.fr/jcms/p_3310940/fr/depistage-du-cancer-bronchopulmonaire-par-scanner-thoracique-faible-dose-sans-injection-actualisation-de-l-avis-de-2016

Leleu, 2020, Lung Cancer Screening by Low-Dose CT Scan: Baseline Results of a French Prospective Study, Clin Lung Cancer, 21, 145, 10.1016/j.cllc.2019.10.014

Leleu, 2022, Results of Second Round Lung Cancer Screening by Low-Dose CT scan – French Cohort Study (DEP-KP80), Clin Lung Cancer, 23, e54, 10.1016/j.cllc.2021.09.009

Couraud, 2013, Physicians’ knowledge and practice of lung cancer screening: a cross-sectional survey comparing general practitioners, thoracic oncologists, and pulmonologists in France, Clin Lung Cancer, 14, 574, 10.1016/j.cllc.2013.05.003

Couraud, 2018, Current and Former Smokers: Who Wants To Be Screened?, Clin Lung Cancer, 19, 493, 10.1016/j.cllc.2018.07.001

Tammemägi, 2022, USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study, Lancet Oncol, 23, 138, 10.1016/S1470-2045(21)00590-8

Couraud, 2016, Lung cancer screening: what is new since the NLST results?, Curr Pulmonol Rep, 5, 130, 10.1007/s13665-016-0139-7

Cazzoli, 2013, microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer, J Thorac Oncol, 8, 1156, 10.1097/JTO.0b013e318299ac32

Sozzi, 2014, Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study, J Clin Oncol, 32, 768, 10.1200/JCO.2013.50.4357

Carozzi, 2010, Molecular profile in body fluids in subjects enrolled in a randomised trial for lung cancer screening: Perspectives of integrated strategies for early diagnosis, Lung Cancer, 68, 216, 10.1016/j.lungcan.2009.06.015

Chen, 2020, Non-invasive early detection of cancer four years before conventional diagnosis using a blood test, Nat Commun, 11, 3475, 10.1038/s41467-020-17316-z

Marquette, 2020, Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study, Lancet Respir Med, 8, 709, 10.1016/S2213-2600(20)30081-3

Sullivan, 2021, Earlier diagnosis of lung cancer in a randomised trial of an autoantibody blood test followed by imaging, Eur Respir J, 57, 2000670

Schumer, 2015, High sensitivity for lung cancer detection using analysis of exhaled carbonyl compounds, J Thorac Cardiovasc Surg, 150, 1517, 10.1016/j.jtcvs.2015.08.092

van de Goor, 2018, Training and Validating a Portable Electronic Nose for Lung Cancer Screening, J Thorac Oncol, 13, 676, 10.1016/j.jtho.2018.01.024

Thông tin
Thông tin xuất bản

Revue des Maladies Respiratoires Actualités

Tập 14

2S37-2S41

Thông tin tác giả